FDA Approved: IBRANCE — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)

View source ↗

Summary

FDA approved a supplemental application for IBRANCE (palbociclib) from Pfizer, indicating an update to the drug's regulatory status (such as labeling or indicat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• IBRANCE (PALBOCICLIB)

Snippet

SUPPL AP for IBRANCE (PALBOCICLIB)